Plain-English translation of NCT04796545 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing the SING IMT System, an implantable telescope that is surgically placed in the eye during cataract surgery. The device is designed to magnify images and help people with advanced age-related macular degeneration (AMD)—a condition that damages central vision—see better. Researchers want to understand how well this device works and whether patients can successfully learn to use it after surgery.
End-stage AMD causes people to lose their central vision, making it very difficult to read, recognize faces, or drive. Current treatments cannot reverse this damage, so there is a need for new solutions to help restore some useful vision in patients who have few other options.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will first be tested with a telescope simulator to confirm the device might help you. If you pass this test, you will undergo outpatient surgery to have the implant placed during cataract surgery. After surgery, you will return for regular eye exams over 12 months and attend 6 to 10 vision training sessions with a specialist to learn how to use your new implant. The research team will monitor your vision, any side effects, and how satisfied you are with the device throughout the study.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Belgium
France
Germany